Is BIIB or UTHR cheaper?

On trailing earnings, UTHR is cheaper: BIIB trades at a 21.42 P/E and UTHR at 20.18.

Which has grown faster, BIIB or UTHR?

Over the past five years, UTHR grew revenue faster — BIIB at a -4.80% CAGR versus UTHR at 16.05%.

Is BIIB or UTHR more profitable?

UTHR runs the higher net margin — BIIB at 13.92% versus UTHR at 40.61%.

Which has been the better investment, BIIB or UTHR?

Over the past 10-year, UTHR delivered the higher annualized total return — BIIB at -2.05% versus UTHR at 17.22%. Past performance doesn't predict future results.

Biogen Inc. (BIIB) vs United Therapeutics Corporation (UTHR)

UTHR leads on 10 of 15 compared metrics.

A side-by-side comparison of Biogen Inc. and United Therapeutics Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 14, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

United Therapeutics Corporation

$23.17B

$545.96Healthcare

Total return — BIIB vs UTHR

growth of $100 · last 27y

BIIB +1743.1%UTHR +8859.3%UTHR compounded faster

BIIB UTHR

BIIB vs UTHR: by the numbers

•BIIB is the larger company ($29.53B vs $23.17B market cap).
•UTHR trades at the lower earnings multiple (20.18 vs 21.42 P/E).
•UTHR converts more revenue to profit (40.61% vs 13.92% net margin).
•UTHR grew revenue faster over the past five years (16.05% vs -4.80% CAGR).

Which is better, BIIB or UTHR?

Metric tally: BIIB 5 · UTHR 10

It depends on what you're optimizing for:

ValueUTHR(lower P/E)

GrowthUTHR(faster 5Y revenue CAGR)

QualityUTHR(higher ROIC)

Valuation

Metric	BIIB	UTHR
P/E ratio	21.42	20.18●
Forward P/E	12.23●	16.48
P/S ratio	3.01●	8.13
P/B ratio	1.59●	4.37
PEG ratio	—	1.16
EV / EBITDA	12.16●	14.41
FCF yield	8.83%●	3.95%

Profitability

Metric	BIIB	UTHR
Gross margin	69.77%	86.58%●
Operating margin	15.65%	45.34%●
Net margin	13.92%	40.61%●
ROE	7.36%	21.82%●
ROIC	6.62%	16.14%●

Growth (annualized)

Metric	BIIB	UTHR
Revenue CAGR (5Y)	-4.80%	16.05%●
EPS CAGR (5Y)	-18.67%	20.93%●
FCF CAGR (5Y)	-3.59%	12.12%●
Total return CAGR (5Y)	-12.79%	24.96%●

Frequently asked

Which is better, BIIB or UTHR?: It depends on your goal. value: UTHR (lower P/E); growth: UTHR (faster 5Y revenue CAGR); quality: UTHR (higher ROIC). Across all compared metrics, UTHR leads 10 to 5.
Is BIIB or UTHR cheaper?: On trailing earnings, UTHR is cheaper: BIIB trades at a 21.42 P/E and UTHR at 20.18.
Which has grown faster, BIIB or UTHR?: Over the past five years, UTHR grew revenue faster — BIIB at a -4.80% CAGR versus UTHR at 16.05%.
Is BIIB or UTHR more profitable?: UTHR runs the higher net margin — BIIB at 13.92% versus UTHR at 40.61%.
Which has been the better investment, BIIB or UTHR?: Over the past 10-year, UTHR delivered the higher annualized total return — BIIB at -2.05% versus UTHR at 17.22%. Past performance doesn't predict future results.

Go deeper

Full BIIB analysis Full UTHR analysis Interactive comparison tool

Dig into the metrics

Biogen P/E ratio United Therapeutics P/E ratio Biogen dividend yield United Therapeutics dividend yield Biogen ROE United Therapeutics ROE Biogen operating margin United Therapeutics operating margin Biogen revenue growth United Therapeutics revenue growth Biogen free cash flow United Therapeutics free cash flow

Biogen & United Therapeutics appear in these rankings

Fastest Revenue Growth Stocks Highest Operating Margin Stocks Highest FCF Yield Stocks Best 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 14, 2026.